Chlorphenamine


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 56.1%
Breast Cancer 8.9%
B-cell Lymphoma 7.9%
Pain 7.5%
Chronic Lymphocytic Leukaemia 2.6%
Drug Exposure During Pregnancy 2.6%
Hepatitis C 2.0%
Oropharyngeal Pain 2.0%
Acne 1.3%
Anxiety 1.3%
Crohn's Disease 1.3%
Infusion 1.0%
Intentional Overdose 1.0%
Musculoskeletal Pain 1.0%
Depression 0.7%
Drug Use For Unknown Indication 0.7%
Prophylaxis 0.7%
Pruritus 0.7%
Upper Respiratory Tract Infection 0.7%
Antacid Therapy 0.3%
Venoocclusive Liver Disease 29.1%
Neuropathy Peripheral 21.8%
Pallor 5.5%
Suicide Attempt 5.5%
Venoocclusive Disease 5.5%
Chest Discomfort 3.6%
Lung Neoplasm Malignant 3.6%
Vomiting 3.6%
Alanine Aminotransferase Increased 1.8%
Blood Alkaline Phosphatase Increased 1.8%
Blood Bilirubin Increased 1.8%
Completed Suicide 1.8%
Dilatation Intrahepatic Duct Acquired 1.8%
Drug Hypersensitivity 1.8%
Dyspnoea 1.8%
Gingival Bleeding 1.8%
Ingrowing Nail 1.8%
Intentional Overdose 1.8%
Jaundice 1.8%
Loss Of Consciousness 1.8%
Concomitant
Product Used For Unknown Indication 43.3%
Premedication 9.5%
Prophylaxis 8.5%
Drug Use For Unknown Indication 6.7%
Nausea 3.6%
B-cell Lymphoma 2.8%
Hypertension 2.7%
Breast Cancer 2.7%
Pain 2.7%
Colorectal Cancer 2.6%
Infection 2.5%
Abdominal Pain 1.9%
Wound Complication 1.9%
Anxiety 1.4%
Cough 1.4%
Epilepsy 1.2%
Acute Lymphocytic Leukaemia Recurrent 1.2%
Constipation 1.1%
Depression 1.1%
Dyspepsia 1.0%
White Blood Cell Count Increased 14.6%
Vomiting 8.2%
Peripheral Motor Neuropathy 7.6%
Urticaria 6.3%
Tachycardia 5.7%
Wheezing 5.1%
Drug Reaction With Eosinophilia And Systemic Symptoms 4.4%
Rash 4.4%
Stevens-johnson Syndrome 4.4%
Unresponsive To Stimuli 4.4%
Infusion Related Reaction 3.8%
Neutropenic Sepsis 3.8%
Paraesthesia 3.8%
Pruritus 3.8%
Respiratory Failure 3.8%
Superinfection 3.8%
Nervous System Disorder 3.2%
Rash Generalised 3.2%
Skin Discolouration 3.2%
Dyspnoea 2.5%

Drug Data